Bausch  Lomb logo

Bausch LombNYSE: BLCO

Profile

Sector:

Healthcare

Country:

Canada

IPO:

06 May 2022

Next earnings report:

21 February 2025

Last dividends:

N/A

Next dividends:

N/A
$6.82 B
-9%vs. 3y high
90%vs. sector
-vs. 3y high
-vs. sector
-7%vs. 3y high
40%vs. sector
-23%vs. 3y high
31%vs. sector

Price

pre-market | 54 min ago
$19.38$0.00(0.00%)

Dividend

No data over the past 3 years
$1.20 B$1.26 B
$1.20 B$4.00 M

Analysts recommendations

Institutional Ownership

BLCO Latest News

Bausch + Lomb Corporation (BLCO) Q3 2024 Earnings Call Transcript
seekingalpha.com30 October 2024 Sentiment: POSITIVE

Bausch + Lomb Corporation (NYSE:BLCO ) Q3 2024 Results Conference Call October 30, 2024 8:00 AM ET Company Participants George Gadkowski - Vice President of Investor Relations and Business Insights Brenton Saunders - CEO & Chairman Osama Eldessouky - Executive VP & CFO Conference Call Participants Patrick Wood - Morgan Stanley Xuyang Li - Jefferies Matt Miksic - Barclays Doug Miehm - RBC Capital Markets Lilia-Celine Lozada - JPMorgan Operator Good morning and welcome to Bausch + Lomb's Third Quarter 2024 Earnings Call. [Operator Instructions] Please note this event is being recorded.

Bausch + Lomb (BLCO) Q3 Earnings and Revenues Top Estimates
zacks.com30 October 2024 Sentiment: POSITIVE

Bausch + Lomb (BLCO) came out with quarterly earnings of $0.17 per share, beating the Zacks Consensus Estimate of $0.16 per share. This compares to earnings of $0.22 per share a year ago.

Why Bausch + Lomb Stock Soared by Over 7% on Monday
https://www.fool.com/investing/2024/10/14/why-bausch-lomb-stock-soared-by-over-7-on-monday/14 October 2024 Sentiment: POSITIVE

It was quite a busy and eventful day for the company.

Bausch & Lomb And Edgewise Therapeutics Are Among Top 7 Mid Cap Stock Gainers Last Week (Sept 15-Sept 21): Are The Others In Your Portfolio?
benzinga.com22 September 2024 Sentiment: POSITIVE

This week, the Federal Reserve's decision to reduce interest rates by 50 basis points boosted share prices across the technology, construction, industrial, machinery, and financial sectors.

Bausch + Lomb (BLCO) Surges 14.5%: Is This an Indication of Further Gains?
zacks.com17 September 2024 Sentiment: POSITIVE

Bausch + Lomb (BLCO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Why Bausch + Lomb Rallied Today
fool.com16 September 2024 Sentiment: POSITIVE

The Financial Times reported Bausch + Lomb is in talks with advisors to potentially sell itself. It had formerly sought to spin off from parent Bausch Health in a stock-for-stock deal.

Bausch + Lomb Stock Jumps Amid Reports Of A Sale
investopedia.com16 September 2024 Sentiment: POSITIVE

Bausch + Lomb (BLCO) shares popped Monday following a report that the eyecare company is considering a sale.

Bausch + Lomb (BLCO) Matches Q2 Earnings Estimates
zacks.com31 July 2024 Sentiment: POSITIVE

Bausch + Lomb (BLCO) came out with quarterly earnings of $0.13 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.18 per share a year ago.

Analysts Estimate Bausch + Lomb (BLCO) to Report a Decline in Earnings: What to Look Out for
zacks.com24 July 2024 Sentiment: NEGATIVE

Bausch + Lomb (BLCO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Bausch + Lomb Announces Presentation of New Data at the European Dry Eye Society 2024 Congress
businesswire.com17 June 2024 Sentiment: POSITIVE

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the presentation of several scientific presentations and educational events during the European Dry Eye Society (EuDEC) 2024 Congress, which will take place in Madrid, Spain, June 20-22. Data presentations highlight the results of several studies evaluating consumer, pharmaceutical and vision care products from.

  • 1(current)

What type of business is Bausch Lomb?

Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, South Korea, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products comprising over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions, such as eye allergies, conjunctivitis, dry eye, and redness relief. Its Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of glaucoma, eye inflammation, ocular hypertension, dry eyes, and retinal diseases. The Surgical segment provides medical device equipment, consumables, and technologies for the treatment of cataracts, corneal, vitreous, and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices for cataract surgery. The company sells its products and services through direct sales forces and independent distributors. Bausch + Lomb Corporation was founded in 1853 and is headquartered in Vaughan, Canada. Bausch + Lomb Corporation operates as a subsidiary of Bausch Health Companies Inc.

What sector is Bausch Lomb in?

Bausch Lomb is in the Healthcare sector

What industry is Bausch Lomb in?

Bausch Lomb is in the Medical Instruments & Supplies industry

What country is Bausch Lomb from?

Bausch Lomb is headquartered in Canada

When did Bausch Lomb go public?

Bausch Lomb initial public offering (IPO) was on 06 May 2022

What is Bausch Lomb website?

https://www.bausch.com

Is Bausch Lomb in the S&P 500?

No, Bausch Lomb is not included in the S&P 500 index

Is Bausch Lomb in the NASDAQ 100?

No, Bausch Lomb is not included in the NASDAQ 100 index

Is Bausch Lomb in the Dow Jones?

No, Bausch Lomb is not included in the Dow Jones index

When was Bausch Lomb the previous earnings report?

No data

When does Bausch Lomb earnings report?

The next expected earnings date for Bausch Lomb is 21 February 2025